Waters, 186004897, ACQUITY UPLC Peptide BEH C18 Method Validation Kit, 300Å, 1.7 µm, 2.1 mm X 100 mm, 1K - 30K, 3/pk

The ACQUITY BEH130 C18 Peptide Columns have been specially optimized and QC tested for peptide separations.  The small-pore (130Å) trifunctionally bonded BEH particle offers the widest usable pH range, superior low pH stability, and ultra-low column bleed to assay samples for proteomics, protein characterization, and peptide synthesis. This kit consists of three ACQUITY UPLC BEH300 C18 Columns packed with three different batches of sorbent.

Specifications
Chemistry: C18
Separation Mode: Reversed Phase
Particle Substrate: Hybrid
pH Range Min: 1 pH
pH Range Max: 12 pH
Maximum Pressure: 15000 psi (1034 Bar)
Endcapped: Yes
Silanol Activity: Low
Molecular Weight Range Min: 1000
Molecular Weight Range Max: 30000
Particle Shape: Spherical
Particle Size: 1.7 µm
Endfitting Type: Parker-style
Pore Size: 300 Å
QC Tested: Peptide
Format: Method Validation Kit
Surface Area: 185
System: UPLC, UHPLC
Particle Technology: BEH
USP Classification: L1
Inner Diameter: 2.1 mm
Length: 100 mm
Carbon Load: 18 %
UNSPSC: 41115709
Application: Peptide
Brand: ACQUITY UPLC
Product Type: Column Kits
Units per Package: 3 pk

FAQ
What Does BEH Technology Refer To? BEH stands for Ethylene Bridged Hybrid-- it is a type of particle available in varying pore sizes and bonded phases, which enables both reversed-phase and hydrophilic interaction chromatography. The BEH particle technology applies to a range of small molecules to large molecule pharmaceutical analysis.